1International Agranulocytosis and Aplastic Anemia Study Group.Incidence of aplastic anemia:the relevance of diagnostic criteria[J].Blood,1987,70:1718-1721.
2Camitta BM,Thomas ED,Nathan DG,et al.Severe aplastic anemia:a prospective study of the effect of early marrow transplantation on acute mortality[J].Blood,1976,48:63-69.
3Bacigalupo A,Hows J,Gluckman E,et al.Bone marrow transplantation (BMT)versus immunosuppression for the treatment of severe aplastic anaemia(SAA):a report of the EBMT SAA Working Party[J].Br J Haematol,1988,70:177-182.
4Young NS,Calado RT,Scheinberg P.Current concepts in the pathophysiology and treatment of aplastic anemia[J].Blood,2006,108:2509-2519.
5Howard SC,Naidu PE,Hu XJ,et al.Natural history of moderate aplastic anemia in children[J].Pediatr Blood Cancer,2004,43:545-551.
6Frickhofen N,Heimpel H,Kaltwasser JP,et al.Antithymocyte globulin with or without cyclosporin A:11 -year follow-up of a randomized trial comparing treatments of aplastic anemia[J].Blood,2003,101:1236-1242.
7Marsh J,Schrezenmeier H,Marin P,et al.Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia:a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party[J].Blood,1999,93:2191-2195.
8Marsh JCW,Ball SE,Darbyshire P,et al.Guidelines for the diagnosis and management of acquired aplastic anaemia[J].Br J Haematol,2003,123:782-801.
9Arranz R,Conde E,Rodriguez-Salvanes F,et al.CsA-based postgraft immunosuppression:the main factor for improving outcome of allografted patients with acquired aplastic anemia-a retrospective survey by the Spanish Group of Hematopoietic Transplantation[J].Bone Marrow Transplant,2002,29:205-211.
10Storb R,Blume KG,O'Donnell MR,et al.Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations:the experience in four centers[J].Biol Blood Marrow Transplant,2001,7:39-44.